CASI Pharmaceuticals, Inc. - Ordinary shares, par value US$0.0001 (CASIF)

CUSIP: G1933S101

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Ordinary shares, par value US$0.0001
Shares outstanding
21,600,641
Total 13F shares
275,894
Share change
-68,714
Total reported value
$1,981,066
Put/Call ratio
57%
Price per share
$7.16
Number of holders
17
Value change
-$338,820
Number of buys
3
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP G1933S101?
CUSIP G1933S101 identifies CASIF - CASI Pharmaceuticals, Inc. - Ordinary shares, par value US$0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary shares, par value US$0.0001 (CASIF) as of Q4 2023

As of 31 Dec 2023, CASI Pharmaceuticals, Inc. - Ordinary shares, par value US$0.0001 (CASIF) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 275,894 shares. The largest 10 holders included Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, MORGAN STANLEY, UBS Group AG, and BlackRock Inc.. This page lists 17 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.